• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

SPACs and Speculative Stock Picking Are Back

There are some big moves for aggressive traders, and they are going after the opportunities hard.
By JAMES "REV SHARK" DEPORRE
Jun 09, 2021 | 06:53 AM EDT
Stocks quotes in this article: ARKK, CLOV

The story of the market in 2021 has been rotation. There has been a series of strong shifts between value, growth, small-caps, big-caps, speculative, and other themes. Traders that have been able to navigate these shifts have performed extremely well, but it has been a very challenging task.

The most significant shift in the market this year occurred around mid-February when speculative favorites and growth stocks were suddenly dumped in favor of value names. This was triggered by the reopening in the economy and the recognition that the 'stay at home' names had likely topped out. Many of the favorite groups like SPACs, biotechnology, cannabis, gambling, EVs, and high-beta growth fell into ugly bear markets. What made this action much worse was that it was not at all reflected in the senior indices that were driven higher mainly by stodgy value names and financials.

The cycle has turned again in recent weeks, with growth names coming back. The ARK Innovation ETF (ARKK) , which is a proxy for some high-beta growth, has bounced off the May lows, and is not trying to overcome some overhead at the 50 and 200 DMA.

The rotation is now favoring the speculative names that topped in February. SPACs had the best action in months on Tuesday, and there are some good-sized gaps in names like Clover (CLOV) this morning. The meme trade is still running, but the speculative focus has shifted to some different names.

This shift in trading was triggered in part by the announcement of the Russell index reconstitution, which will take place at the end of the month. The list contains a number of stocks that have completed SPAC transactions and are now being rediscovered as offering attractive valuations.

The senior indices are flat and not doing much, but the stock-picking under the surface is fast and furious again. This sort of action did lead to the top in February, so we will have to watch for frothiness in the speculative names, but currently, there are some big moves for aggressive traders, and they are going after the opportunities hard.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, James "Rev Shark" DePorre had no position in the securities mentioned.

TAGS: Investing | Markets | Stocks | Trading

More from Investing

Enanta Pharmaceuticals Bounces Off a Key Support Level Once Again

Bruce Kamich
Jul 1, 2022 9:41 AM EDT

The shares of the biotech company appear to be finding a bottom but could use more sideways action to create a better base.

CRISPR Therapeutics Has Turned the Corner

Bruce Kamich
Jul 1, 2022 8:43 AM EDT

Here's our current price target.

A Few Thoughts on How to Approach a Tougher Bear Market Than Most

Bob Byrne
Jul 1, 2022 8:30 AM EDT

A key goal is to keep from losing money while the current bear runs its course, and don't count on positive seasonality leading to the Fourth of July.

Four Things I Know for Sure About the Market

James "Rev Shark" DePorre
Jul 1, 2022 8:06 AM EDT

As the second half of 2022 begins, keep this quarter of observations in mind.

Little-Known Akoya Biosciences Appears to Have Found a Bottom

Bruce Kamich
Jul 1, 2022 7:53 AM EDT

The stock of the life sciences company has found buying interest at a key support level.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:59 PM EDT PAUL PRICE

    Very good quarterly numbers from Bassett Furniture (BSET)

    Bassett Furniture (BSET) blew right through analys...
  • 04:41 PM EDT PAUL PRICE

    First Half Results - Putrid Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 marked...
  • 04:51 PM EDT PAUL PRICE

    We Should Be in for Better Starting Soon

    Window dressing Thursday, the last day of the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login